DTx Pharma to Present at the Chardan Virtual 4th Annual Genetic Medicines Event
PR Newswire, San Diego – September 28, 2020 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the [...]
DTx Pharma Receives New Funding Grant to Advance RNA-based Therapeutic Programs for Charcot-Marie Tooth (CMT)
-CMT is a genetic rare disease driven by the duplication of the PMP22 gene- PR Newswire, San Diego – September 21, 2020 – DTx Pharma, [...]
DTx Pharma Announces Presentations at Several Upcoming Virtual Medical Meetings
DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that the company will [...]